Author

Alliefair Scalise

Cleveland ClinicORCID 0009-0002-3743-4366Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Anthony R. SloaniD· 2 shared Anu AggarwaliD· 2 shared Bhairavi RajasekariD· 2 shared Justin Durla LathiaiD· 2 shared Naseer SangwaniD· 2 shared Scott J. CameroniD· 2 shared Aarav Badani· 1 shared Alex Vincenti· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anthony R. SloanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signaling

Anthony R. Sloan, George Bukenya, Gavin P. Tannish, Daniel J. Silver, Anu Aggarwal, Juyeun Lee, Daniel Rosoff, Tyler J. Alban, Ivan Juric, Shikha Parsai, Vargab Baruah, Tyler Bodovetz, Donovan Whitfield, Liza Tack, Tanvi Navadgi, , Justin Durla Lathia

This study shows that platelet PAR4 signaling, interacting with estrogen receptor beta, drives glioblastoma progression and immune suppression, with sex-specific effects on survival and TME dynamics.

Cancer Cell · Oct 1, 2026Peer-reviewedCancer Biology

Targeting an Olfactory Receptor Mitigates High Residual Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Depolymerization

Anu Aggarwal, Vara Prasad VN Josyula, Nancy Wang, Moua Yang, Young Jun Shim, Quinn Patrick Kennedy, Reina Samuel, Naseer Sangwan, Suman Guntupalli, Matthew Godwin, Huijun Edelyn Park, Mariya Ali, Courtney Jennings, Bhairavi Rajasekar, Alliefair Scalise, , Scott J. Cameron

The paper identifies OR2L13 agonists that reduce platelet reactivity and thrombosis by depolymerizing the actin cytoskeleton through HSP27 phosphorylation.

Circulation · Apr 7, 2026Peer-reviewedPhysiology